Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Not Confirmed
Not Confirmed
27-30 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Industry Trade Show
Not Confirmed
27-30 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
01 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/01/3108201/0/en/Verrica-Pharmaceuticals-Announces-Amendment-to-Collaboration-and-License-Agreement-with-Torii-Pharmaceutical-to-Launch-Global-Pivotal-Phase-3-Clinical-Trial-to-Study-YCANTH-for-the.html
08 May 2025
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/japans-shionogi-buy-torii-pharmaceutical-1-billion-nikkei-says-2025-05-07/
15 May 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/05/15/2882311/0/en/Verrica-Pharmaceuticals-Announces-Amendment-to-Company-s-Collaboration-and-License-Agreement-with-Torii-Pharmaceutical-Co-Ltd-to-Fund-Global-Pivotal-Phase-3-Clinical-Trial-to-Study.html
15 Dec 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/12/15/2796913/0/en/Verrica-Pharmaceuticals-Development-and-Commercialization-Partner-Torii-Pharmaceutical-Co-Ltd-Announces-Positive-Top-line-Results-from-a-Confirmatory-Phase-3-Trial-of-TO-208-for-th.html
01 Aug 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/08/01/2489298/0/en/Verrica-Pharmaceuticals-Announces-Start-of-Phase-3-Trial-of-VP-102-for-the-Treatment-of-Molluscum-Contagiosum-by-Torii-Pharmaceutical-Co-Ltd-in-Japan.html
17 Mar 2021
// GLOBENEWSWIRE
https://www.globenewswire.com/fr/news-release/2021/03/17/2194392/0/en/Verrica-Pharmaceuticals-Announces-Exclusive-Licensing-Agreement-With-Torii-Pharmaceutical-Co-Ltd-To-Develop-and-Commercialize-VP-102-For-Molluscum-and-Common-Warts-in-Japan.html
ABOUT THIS PAGE